These updated guidelines provide recommendations for the treatment of adults with spasticity with botulinum toxin as part of an overall patient management programme.
Acute kidney injury (AKI) is a common condition that involves sudden, catastrophic loss of kidney function. It is estimated that AKI is associated with one in five emergency hospital admissions and causes up to 1.7 million deaths globally per year.
This NICE guideline covers assessment, diagnosis and referral for people over 16 who have had a transient loss of consciousness (TLoC; also called a blackout).